Neoadjuvant ceritinib treatment achieved pathological complete response in patients with anaplastic lymphoma kinase positive stage IIIA-N2 non-small cell lung cancer

被引：0
|
作者：
Shen, Qian [1 ]
Gao, Qiqi [2 ]
Zhou, Jianying [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Thorac Dis Ctr,Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2023年 / 136卷 / 07期
关键词：
D O I：
10.1097/CM9.0000000000002403
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：851 / 853
页数：3
相关论文
共 50 条
  • [21] Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer
    Xiao Ding
    Honghai Dai
    Zhouguang Hui
    Wei Ji
    Jun Liang
    Jima Lv
    Zongmei Zhou
    Weibo Yin
    Jie He
    Luhua Wang
    Radiation Oncology, 7
  • [22] Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy
    Hui, Zhouguang
    Dai, Honghai
    Liang, Jun
    Lv, Jima
    Zhou, Zongmei
    Feng, Qinfu
    Xiao, Zefen
    Chen, Dongfu
    Zhang, Hongxing
    Yin, Weibo
    Wang, Luhua
    THORACIC CANCER, 2015, 6 (03) : 346 - 353
  • [23] Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer
    Ding, Xiao
    Dai, Honghai
    Hui, Zhouguang
    Ji, Wei
    Liang, Jun
    Lv, Jima
    Zhou, Zongmei
    Yin, Weibo
    He, Jie
    Wang, Luhua
    RADIATION ONCOLOGY, 2012, 7
  • [24] Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer
    Hu, Yi-Ming
    Li, Jing
    Yu, Li-Chao
    Shi, Shun-Bing
    Du, Yong-Jie
    Wu, Jian-Nong
    Shi, Wei Lin
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (02) : 257 - 265
  • [25] Lorlatinib for the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer
    Yang, Junyi
    Gong, Weiliang
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (03) : 173 - 178
  • [26] Diagnosis and Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
    Arbour, Kathryn C.
    Riely, Gregory J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 101 - +
  • [27] Postoperative radiotherapy in non-small cell lung cancer stage IIIA-N2: Focus and perspectives
    Wang, Pascal
    Duchemann, Boris
    Chouahnia, Kader
    Matton, Lise
    Benabadji, Ambre
    Zelek, Laurent
    Popotte, Hosni
    Paix, Adrien
    BULLETIN DU CANCER, 2023, 110 (01) : 101 - 112
  • [28] The Optimal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer: A Network Meta-Analysis
    Zhao, Yi
    Wang, Wei
    Liang, Hengrui
    Yang, Chi-Fu Jeffrey
    D'Amico, Thomas
    Ng, Calvin S. H.
    Liu, Chia-chuan
    Petersen, Rene Horsleben
    Rocco, Gaetano
    Brunelli, Alessandro
    Liu, Jun
    He, Jiaxi
    Huang, Weizhe
    Liang, Wenhua
    He, Jianxing
    ANNALS OF THORACIC SURGERY, 2019, 107 (06): : 1866 - 1875
  • [29] Postoperative Radiotherapy in Completely Resected Stage IIIA-N2 Non-Small Cell Lung Cancer
    Ahn, S.
    Na, K.
    Kim, Y.
    Song, S.
    Oh, I.
    Park, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2180 - S2181
  • [30] Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!
    Berzenji, Lawek
    Beckers, Paul
    Van Schil, Paul E.
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S1153 - S1156
12345